Press Releases
FDA Approves Gilead’s Epclusa for the Treatment of All...
Gilead Sciences, Inc. announced that the U.S. FDA has approved Epclusa , the first all-oral, pan-genotypic, single tablet regimen for the treatment of adults with...
Press Releases
Merck, Premier Inc collaborate to improve care for osteoporosis...
Merck and Premier Inc , a leading healthcare improvement company, have agreed to collaborate on the co-development of solutions to help improve population health. Initially,...
Press Releases
Novartis’ midostaurin achieves 60% response rate in advanced systemic...
Novartis announced that The New England Journal of Medicine published data for PKC412 demonstrating an overall response rate, defined as a major or partial response,...
Press Releases
EU approves Astrazeneca Plc’s New Antibiotic Zavicefta
AstraZeneca announced that the EC has granted marketing authorisation for Zavicefta , a new combination antibiotic for the treatment of patients with serious Gram-negative bacterial...
Press Releases
FDA accepted Teva’s Fluticasone Propionate and Fluticasone Propionate RespiClick...
Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has accepted for review the company’s new drug applications (NDAs) for two products for adolescent and...
Press Releases
Novo Nordisk receives the EMA marketing approval of the...
Novo Nordisk announces the EMA marketing approval of the mylife(TM) YpsoPump® insulin pump for use with prefilled pump cartridge NovoRapid®PumpCart®. The approval is a key...
Press Releases
Pfizer says Two additional late stage studies of cholesterol...
Pfizer Inc. announced two additional Phase 3 bococizumab trials, SPIRE-HR and SPIRE-FH , met their primary endpoint, demonstrating a significant reduction in the percent change...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.